View Item 

Show simple item record

Commentary: risk factors for gastrointestinal bleeding in NSAID users – authors’ reply
dc.contributor.authorLanas, A.en_US
dc.contributor.authorGoldstein, J.en_US
dc.contributor.authorChan, F. K. L.en_US
dc.contributor.authorWilcox, C. M.en_US
dc.contributor.authorPeura, D. A.en_US
dc.contributor.authorLi, C.en_US
dc.contributor.authorSands, G. H.en_US
dc.contributor.authorScheiman, J. M.en_US
dc.date.accessioned2012-11-07T17:04:45Z
dc.date.available2014-01-07T14:51:08Zen_US
dc.date.issued2012-11en_US
dc.identifier.citationLanas, A.; Goldstein, J.; Chan, F. K. L.; Wilcox, C. M.; Peura, D. A.; Li, C.; Sands, G. H.; Scheiman, J. M. (2012). "Commentary: risk factors for gastrointestinal bleeding in NSAID users – authors’ reply." Alimentary Pharmacology & Therapeutics (9): 905-905. <http://hdl.handle.net/2027.42/94297>en_US
dc.identifier.issn0269-2813en_US
dc.identifier.issn1365-2036en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/94297
dc.publisherWiley Periodicals, Inc.en_US
dc.titleCommentary: risk factors for gastrointestinal bleeding in NSAID users – authors’ replyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/94297/1/apt12056.pdf
dc.identifier.doi10.1111/apt.12056en_US
dc.identifier.sourceAlimentary Pharmacology & Therapeuticsen_US
dc.identifier.citedreferenceGoldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3: 133 – 41.en_US
dc.identifier.citedreferenceHunt RH, Bowen B, Mortensen ER, et al. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects. Am J Med 2000; 109: 201 – 6.en_US
dc.identifier.citedreferenceGoldstein JL, Eisen GM, Lewis B, et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007; 25: 1211 – 22.en_US
dc.identifier.citedreferenceHawkey CJ. Commentary: risk factors for gastrointestinal bleeding in NSAID users. Aliment Pharmacol Ther 2012; 36: 904.en_US
dc.identifier.citedreferenceLanas A, Goldstein JL, Chan FKL, et al. Risk factors associated with a decrease ≥ 2 g/dL in haemoglobin and/or ≥ 10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR). Aliment Pharmacol Ther 2012; 36: 485 – 92.en_US
dc.identifier.citedreferenceChan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Celecoxib versus omeprazole diclofenac in patients with osteoarthritis rheumatoid arthritis (CONDOR): a randomised trial. Lancet 2010; 376: 173 – 9.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
apt12056.pdf
Size:
54.13KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.